International Journal of Environmental Research and Public Health Article Real World Use of Antidiabetic Drugs in the Years 2011–2017: A Population-Based Study from Southern Italy Ylenia Ingrasciotta 1,* , Maria Paola Bertuccio 1 , Salvatore Crisafulli 1, Valentina Ientile 1, Marco Muscianisi 2 , Luca L’Abbate 1, Maurizio Pastorello 3, Vincenzo Provenzano 4, Alessandro Scorsone 4, Salvatore Scondotto 5 and Gianluca Trifirò 6 1 Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, 98125 Messina, Italy;
[email protected] (M.P.B.);
[email protected] (S.C.);
[email protected] (V.I.);
[email protected] (L.L.) 2 Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy;
[email protected] 3 Palermo Local Health Unit, Department of Pharmacy, 90127 Palermo, Italy;
[email protected] 4 Regional Referral Centre for Insulin Pump Implantation and Diabetes, Civic Hospital, Partinico, 90047 Palermo, Italy;
[email protected] (V.P.);
[email protected] (A.S.) 5 Department of Epidemiologic Observatory, Health Department of Sicily, 90127 Palermo, Italy;
[email protected] 6 Department of Diagnostic and Public Health, University of Verona, 37134 Verona, Italy; gianluca.trifi
[email protected] * Correspondence:
[email protected]; Tel.: +39-090-2213877 Received: 19 November 2020; Accepted: 16 December 2020; Published: 18 December 2020 Abstract: Diabetes mellitus is a metabolic disease characterized by chronic hyperglycemia. The availability of new antidiabetic drugs (ADs) has led to complex treatment patterns and to changes in the patterns of specific drug utilization. The aim of this population-based study was to describe the pattern of antidiabetic drugs (ADs) use in Southern Italy in the years 2011–2017, in relation to the updated type 2 diabetes mellitus (T2DM) therapy guidelines.